Two Sigma Advisers LP Invests $436,000 in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Two Sigma Advisers LP purchased a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 38,800 shares of the company's stock, valued at approximately $436,000.

Other large investors have also recently added to or reduced their stakes in the company. Point72 Asset Management L.P. bought a new stake in Alignment Healthcare in the fourth quarter valued at $20,087,000. ProShare Advisors LLC lifted its stake in Alignment Healthcare by 49.0% in the fourth quarter. ProShare Advisors LLC now owns 28,188 shares of the company's stock valued at $317,000 after buying an additional 9,274 shares during the last quarter. Millennium Management LLC lifted its stake in Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after buying an additional 2,896,311 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Alignment Healthcare by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company's stock valued at $641,000 after buying an additional 2,154 shares during the last quarter. Finally, Integral Health Asset Management LLC bought a new stake in Alignment Healthcare in the fourth quarter valued at $5,625,000. 86.19% of the stock is currently owned by institutional investors.

Insider Activity

In other Alignment Healthcare news, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the company's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $15.28, for a total transaction of $259,760,000.00. Following the completion of the sale, the director now owns 44,302,175 shares of the company's stock, valued at $676,937,234. This represents a 27.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Andreas P. Wagner sold 7,632 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total value of $125,164.80. Following the sale, the insider now directly owns 223,474 shares of the company's stock, valued at $3,664,973.60. The trade was a 3.30% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 17,784,649 shares of company stock worth $273,320,208 in the last three months. 7.00% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on ALHC shares. Stifel Nicolaus raised their price target on Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a report on Tuesday, April 8th. UBS Group lifted their price target on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. William Blair reaffirmed an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the company a "neutral" rating in a research note on Thursday, March 6th. One analyst has rated the stock with a sell rating, three have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $17.17.

Alignment Healthcare Stock Up 2.9%

Shares of Alignment Healthcare stock traded up $0.43 during trading on Friday, hitting $15.22. 1,951,057 shares of the stock traded hands, compared to its average volume of 2,015,584. The stock has a market cap of $3.01 billion, a P/E ratio of -19.77 and a beta of 1.22. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a twelve month low of $7.05 and a twelve month high of $21.06. The company has a fifty day moving average price of $16.70 and a two-hundred day moving average price of $14.84.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.07. The business had revenue of $926.93 million during the quarter, compared to analyst estimates of $889.83 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The firm's revenue was up 47.5% on a year-over-year basis. During the same period in the previous year, the company earned ($0.25) EPS. Equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.